Guardion Health Sciences Performance
| GHSIDelisted Stock | USD 3.29 0.04 1.23% |
On a scale of 0 to 100, Guardion Health holds a performance score of 1. The company retains a Market Volatility (i.e., Beta) of -0.1, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Guardion Health are expected to decrease at a much lower rate. During the bear market, Guardion Health is likely to outperform the market. Please check Guardion Health's coefficient of variation, semi variance, price action indicator, as well as the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Guardion Health's current trending patterns will revert.
Risk-Adjusted Performance
1 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Guardion Health Sciences are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite fairly inconsistent basic indicators, Guardion Health may actually be approaching a critical reversion point that can send shares even higher in December 2024. ...more
| Begin Period Cash Flow | 15.9 M |
Guardion |
Guardion Health Relative Risk vs. Return Landscape
If you would invest 374.00 in Guardion Health Sciences on August 28, 2024 and sell it today you would lose (45.00) from holding Guardion Health Sciences or give up 12.03% of portfolio value over 90 days. Guardion Health Sciences is currently generating 0.1953% in daily expected returns and assumes 9.7389% risk (volatility on return distribution) over the 90 days horizon. In different words, 86% of pink sheets are less volatile than Guardion, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Guardion Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Guardion Health's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Guardion Health Sciences, and traders can use it to determine the average amount a Guardion Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0201
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | GHSI | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 9.74 actual daily | 86 86% of assets are less volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.02 actual daily | 1 99% of assets perform better |
Based on monthly moving average Guardion Health is performing at about 1% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Guardion Health by adding it to a well-diversified portfolio.
Guardion Health Fundamentals Growth
Guardion Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Guardion Health, and Guardion Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Guardion Pink Sheet performance.
| Return On Equity | -0.5 | |||
| Return On Asset | -0.16 | |||
| Profit Margin | 0.52 % | |||
| Operating Margin | (18.75) % | |||
| Current Valuation | (987.33 K) | |||
| Shares Outstanding | 1.35 M | |||
| Price To Earning | (0.71) X | |||
| Price To Book | 0.32 X | |||
| Price To Sales | 0.36 X | |||
| Revenue | 12.25 M | |||
| EBITDA | (3.92 M) | |||
| Cash And Equivalents | 14.23 M | |||
| Cash Per Share | 0.23 X | |||
| Total Debt | 3.77 M | |||
| Book Value Per Share | 10.71 X | |||
| Cash Flow From Operations | (4.37 M) | |||
| Earnings Per Share | (4.11) X | |||
| Total Asset | 11.92 M | |||
| Retained Earnings | (93.57 M) | |||
| Current Asset | 12.8 M | |||
| Current Liabilities | 466.01 K | |||
About Guardion Health Performance
By evaluating Guardion Health's fundamental ratios, stakeholders can gain valuable insights into Guardion Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Guardion Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Guardion Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California. Guardion Health operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 13 people.Things to note about Guardion Health Sciences performance evaluation
Checking the ongoing alerts about Guardion Health for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Guardion Health Sciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Guardion Health is not yet fully synchronised with the market data | |
| Guardion Health had very high historical volatility over the last 90 days | |
| Guardion Health has a very high chance of going through financial distress in the upcoming years | |
| Guardion Health Sciences currently holds about 14.23 M in cash with (4.37 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.23. |
- Analyzing Guardion Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Guardion Health's stock is overvalued or undervalued compared to its peers.
- Examining Guardion Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Guardion Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Guardion Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Guardion Health's pink sheet. These opinions can provide insight into Guardion Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Guardion Pink Sheet
If you are still planning to invest in Guardion Health Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Guardion Health's history and understand the potential risks before investing.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |